ibanti 80 80 mg comprimido recubierto
laboratorios roemmers s.a. - droguerÍa - comprimido recubierto - por comprimido - - lurasidona
ibanti 40 40 mg comprimido recubierto
laboratorios roemmers s.a. - droguerÍa - comprimido recubierto - por comprimido - - lurasidona
virpas®
strides pharma science ltd. - sofosbuvir; dispersión seca de ledipasvir atomizada (premezcla ledipasvir: copovidona 1:1) - tableta revestida - 400 mg; 180 mg
ledipasvir y sofosbuvir
natco pharma limited. - ledipasvir; sofosbuvir - tableta revestida - 90 mg; 400 mg
trulicity recombinante solución inyectable 0,75 mg/ 0,5 ml (dulaglutida) dna recombinante)
tecnofarma s.a. - dulaglutida - sin formulas
trulicity recombinante solución inyectable 1,5 mg/0,5 ml (dulaglutida)
tecnofarma s.a. - dulaglutida - sin formulas
trulicity recombinante solución inyectable 1,5mg/0,5ml (dulaglutida)
tecnofarma s.a. - dulaglutida - sin formulas
trulicity recombinante solución inyectable 0,75 mg/ 0,5ml ( dulaglutida)
tecnofarma s.a. - dulaglutida - sin formulas
mounjaro
eli lilly nederland b.v. - tirzepatide - diabetes mellitus, tipo 2 - drogas usadas en diabetes - mounjaro is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise- as monotherapy when metformin is considered inappropriate due to intolerance or contraindications- in addition to other medicinal products for the treatment of diabetes. for study results with respect to combinations, effects on glycaemic control and the populations studied, see sections 4. 4, 4. 5 y 5.
triumeq 5/60/30 comprimidos dispersables
glaxosmithkline chile farmacÉutica ltda. - abacavir; dolutegravir; lamivudina - sin formulas